Juvenile Idiopathic Arthritis Differential Diagnoses
- Author: David D Sherry, MD; Chief Editor: Lawrence K Jung, MD more...
Diagnostic Considerations
Arthritis or arthritis-like symptoms may be present in many conditions. Leukemia is the single most important disease that is mistaken for juvenile idiopathic arthritis (JIA).
Leukemia
Patients with acute lymphocytic leukemia can present with joint pain and arthritis. Expansion of lymphoblasts in bone metaphyses results in pain, which is typically severe and may awaken the child from sleep. Thrombocytopenia is rare in children with JIA; its presence suggests the possibility of leukemia. Lymphocytosis is also uncharacteristic of JIA and likewise raises the possibility of leukemia, particularly when neutropenia is present.
Additional differential diagnoses
Postinfectious arthritis typically affects large joints. This syndrome is clinically indistinguishable from the early phase of JIA, particularly because onset of JIA may be triggered by viral infections; a duration of longer than 6 weeks eventually differentiates JIA.
Acute joint inflammation from JIA needs to be differentiated from septic arthritis, because the 2 disorders may produce a similar clinical picture, with warmth, acute pain, and severely painful range of motion. Although polyarticular symmetrical involvement and distinctive clinical features help to differentiate JIA from pyogenic arthritis, joint aspiration and joint fluid analysis may be indicated.
Thrombocytopenia may be observed in patients with systemic lupus erythematosus (SLE) who present with arthritis, as well as in those with marrow-occupying malignancies (eg, acute lymphocytic leukemia). Thrombocytosis reflects an inflammatory state and often mirrors inflammatory markers in JIA.
Severe joint pain raises the possibility of acute rheumatic fever (also suggested by migratory, but not additive, arthritis with fevers), malignancy with bone marrow–occupying cancers (eg, neuroblastoma, acute lymphocytic leukemia), septic arthritis, and osteomyelitis.
Weight loss without diarrhea is rarely observed in individuals with active JIA but is sometimes associated with anorexia in those with systemic disease. Weight loss is also found in individuals with malignancy, such as acute lymphocytic leukemia or inflammatory bowel disease.
Monoarticular arthritis in a hip is highly unusual in JIA. For isolated hip arthritis, consider Legg-Calvé-Perthes disease, toxic synovitis of the hip, septic arthritis, osteomyelitis, or, in an older child, slipped capital femoral epiphysis or chondrolysis of the hip.
A history of illness in pets and enteritis indicates that the patient might be suffering from reactive arthritis. A history of travel to an endemic area with exposure to ticks suggests the possibility of Lyme disease.
GI symptoms, microcytic anemia, and elevated inflammatory markers raise the possibility of inflammatory bowel disease.
Differential Diagnoses
- Behcet Syndrome
- Infectious Mononucleosis
- Kawasaki Disease
- Lyme Disease
- Pediatric Acute Lymphoblastic Leukemia
- Pediatric Kawasaki Disease
- Pediatric Sarcoidosis
- Pericarditis, Viral
- Somatoform Disorder: Pain
- Systemic Lupus Erythematosus
Lamer S, Sebag GH. MRI and ultrasound in children with juvenile chronic arthritis. Eur J Radiol. Feb 2000;33(2):85-93. [Medline].
Argyropoulou MI, Margariti PN, Karali A, Astrakas L, Alfandaki S, Kosta P, et al. Temporomandibular joint involvement in juvenile idiopathic arthritis: clinical predictors of magnetic resonance imaging signs. Eur Radiol. Mar 2009;19(3):693-700. [Medline].
Lee EY, Sundel RP, Kim S, Zurakowski D, Kleinman PK. MRI findings of juvenile psoriatic arthritis. Skeletal Radiol. Nov 2008;37(11):987-96. [Medline].
Barton A, Worthington J. Genetic susceptibility to rheumatoid arthritis: an emerging picture. Arthritis Rheum. Oct 15 2009;61(10):1441-6. [Medline].
Hinks A, Ke X, Barton A, Eyre S, Bowes J, Worthington J, et al. Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis. Arthritis Rheum. Jan 2009;60(1):251-7. [Medline]. [Full Text].
Yanagimachi M, Miyamae T, Naruto T, Hara T, Kikuchi M, Hara R, et al. Association of HLA-A(*)02:06 and HLA-DRB1(*)04:05 with clinical subtypes of juvenile idiopathic arthritis. J Hum Genet. Mar 2011;56(3):196-9. [Medline].
Scola MP, Imagawa T, Boivin GP, Giannini EH, Glass DN, Hirsch R, et al. Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice. Arthritis Rheum. Apr 2001;44(4):794-801. [Medline].
Wittkowski H, Frosch M, Wulffraat N, Goldbach-Mansky R, Kallinich T, Kuemmerle-Deschner J, et al. S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis Rheum. Dec 2008;58(12):3924-31. [Medline]. [Full Text].
Ayaz NA, Ozen S, Bilginer Y, Ergüven M, Taskiran E, Yilmaz E, et al. MEFV mutations in systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford). Jan 2009;48(1):23-5. [Medline].
Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. Jan 2008;58(1):15-25. [Medline]. [Full Text].
Orphanet. Enthesitis-related arthritis. Available at http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=85438.
Sullivan DB, Cassidy JT, Petty RE. Pathogenic implications of age of onset in juvenile rheumatoid arthritis. Arthritis Rheum. May-Jun 1975;18(3):251-5. [Medline].
Simard JF, Neovius M, Hagelberg S, Askling J. Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study. Arthritis Rheum. Dec 2010;62(12):3776-82. [Medline].
Cassidy J, Kivlin J, Lindsley C, Nocton J. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. May 2006;117(5):1843-5. [Medline].
Lovell DJ. Juvenile Idiopathic Arthritis: Clinical Features. In: Kippel JH, Stone JH, Crofford LJ, White PH, Eds. Primer on the Rheumatic Diseases. 13th Ed. Springer Science, New York: 2008.
Johnson K, Gardner-Medwin J. Childhood arthritis: classification and radiology. Clin Radiol. Jan 2002;57(1):47-58. [Medline].
McHugh K, Gupta R, Murray K. Imaging in juvenile chronic arthritis. Imaging. 1999;11:91-7.
Pedersen TK, Küseler A, Gelineck J, Herlin T. A prospective study of magnetic resonance and radiographic imaging in relation to symptoms and clinical findings of the temporomandibular joint in children with juvenile idiopathic arthritis. J Rheumatol. Aug 2008;35(8):1668-75. [Medline].
Gylys-Morin VM. MR imaging of pediatric musculoskeletal inflammatory and infectious disorders. Magn Reson Imaging Clin N Am. Aug 1998;6(3):537-59. [Medline].
Workie DW, Graham TB, Laor T, Rajagopal A, O'Brien KJ, Bommer WA, et al. Quantitative MR characterization of disease activity in the knee in children with juvenile idiopathic arthritis: a longitudinal pilot study. Pediatr Radiol. Jun 2007;37(6):535-43. [Medline].
Nistala K, Babar J, Johnson K, Campbell-Stokes P, Foster K, Ryder C, et al. Clinical assessment and core outcome variables are poor predictors of hip arthritis diagnosed by MRI in juvenile idiopathic arthritis. Rheumatology (Oxford). Apr 2007;46(4):699-702. [Medline].
Shanmugavel C, Sodhi KS, Sandhu MS, Sidhu R, Singh S, Katariya S, et al. Role of power Doppler sonography in evaluation of therapeutic response of the knee in juvenile rheumatoid arthritis. Rheumatol Int. Apr 2008;28(6):573-8. [Medline].
American College of Rheumatology, Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum. Feb 2002;46(2):328-46. [Medline].
Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, Dewitt EM, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). Apr 2011;63(4):465-82. [Medline].
Efficacy and safety of tocilizumab in patients with systemic Juvenile Idiopathic Arthritis (sJIA): 12-week data from the phase 3 TENDER trial. Abstract presented on June 18, 2010. European League Against Rheumatism (EULAR). [Full Text].
Otten MH, Prince FH, Armbrust W, et al. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis. JAMA. Dec 7 2011;306(21):2340-7. [Medline].
American College of Rheumatology, Section on Pediatric Rheumatology. Position statement: guidelines for referral of children and adolescents to pediatric rheumatologists. Available at http://www.rheumatology.org/sections/pediatric/ped_referral.pdf. Accessed November 11, 1997.
Chmell MJ, Scott RD, Thomas WH, Sledge CB. Total hip arthroplasty with cement for juvenile rheumatoid arthritis. Results at a minimum of ten years in patients less than thirty years old. J Bone Joint Surg Am. Jan 1997;79(1):44-52. [Medline].
Dabov G, Perez EA. Miscellaneous nontraumatic disorders: rheumatoid arthritis. In: Canale ST, ed. Campbell's Operative Orthopaedics. 10th ed. St Louis, Mo: Mosby; 2003.
Delf Witt J. Surgical intervention and sports medicine: surgery in children. In: Isenberg D, Maddison P, Woo P, et al, eds. Oxford Textbook of Rheumatology. New York, NY: Oxford University Press; 2004:1220-8.
Goodman SB, Oh KJ, Imrie S, Hwang K, Shegog M. Revision total hip arthroplasty in juvenile chronic arthritis: 17 revisions in 11 patients followed for 4-12 years. Acta Orthop. Apr 2006;77(2):242-50. [Medline].
Hanson V, Kornreich HK, Bernstein B, et al. subtypes of juvenile rheumatoid arthritis (correlations of age at onset, sex, and serologic factors). Arthritis Rheum. (Suppl): 20;48(1):184.
Ilowite NT. Current treatment of juvenile rheumatoid arthritis. Pediatrics. Jan 2002;109(1):109-15. [Medline].
[Best Evidence] Kapetanovic MC, Lindqvist E, Saxne T, Eberhardt K. Orthopaedic surgery in patients with rheumatoid arthritis over 20 years: prevalence and predictive factors of large joint replacement. Ann Rheum Dis. Oct 2008;67(10):1412-6. [Medline].
Lehtimäki MY, Lehto MU, Kautiainen H, Savolainen HA, Hämäläinen MM. Survivorship of the Charnley total hip arthroplasty in juvenile chronic arthritis. A follow-up of 186 cases for 22 years. J Bone Joint Surg Br. Sep 1997;79(5):792-5. [Medline].
Lybäck CO, Lehto MU, Hämäläinen MM, Belt EA. Patellar resurfacing reduces pain after TKA for juvenile rheumatoid arthritis. Clin Orthop Relat Res. Jun 2004;152-6. [Medline].
McCullough CJ. Surgical management of the hip in juvenile chronic arthritis. Br J Rheumatol. Feb 1994;33(2):178-83. [Medline].
Mulhall KJ, Saleh KJ, Thompson CA, Severson EP, Palmer DH. Results of bilateral combined hip and knee arthroplasty in very young patients with juvenile rheumatoid arthritis. Arch Orthop Trauma Surg. Mar 2008;128(3):249-54. [Medline].
Odent T, Journeau P, Prieur AM, Touzet P, Pouliquen JC, Glorion C. Cementless hip arthroplasty in juvenile idiopathic arthritis. J Pediatr Orthop. Jul-Aug 2005;25(4):465-70. [Medline].
Oh KJ, Imrie S, Hwang K, Ramachandran R, Shegog M, Goodman SB. Total hip arthroplasty using the miniature Anatomic Medullary Locking stem. Clin Orthop Relat Res. Jun 2006;447:85-91. [Medline].
Palmer DH, Mulhall KJ, Thompson CA, Severson EP, Santos ER, Saleh KJ. Total knee arthroplasty in juvenile rheumatoid arthritis. J Bone Joint Surg Am. Jul 2005;87(7):1510-4. [Medline].
Thomas A, Rojer D, Imrie S, Goodman SB. Cemented total knee arthroplasty in patients with juvenile rheumatoid arthritis. Clin Orthop Relat Res. Apr 2005;140-6. [Medline].
Williams WW, McCullough CJ. Results of cemented total hip replacement in juvenile chronic arthritis. A radiological review. J Bone Joint Surg Br. Nov 1993;75(6):872-4. [Medline].
Wroblewski BM, Siney PD, Fleming PA. Charnley low-frictional torque arthroplasty in young rheumatoid and juvenile rheumatoid arthritis: 292 hips followed for an average of 15 years. Acta Orthop. Apr 2007;78(2):206-10. [Medline].
Yun AG, Martin S, Zurakowski D, Scott R. Bipolar hemiarthroplasty in juvenile rheumatoid arthritis: long-term survivorship and outcomes. J Arthroplasty. Dec 2002;17(8):978-86. [Medline].
| Classification | ACR(1977) | ILAR (1997) |
| Nomenclature | Juvenile rheumatoid arthritis | Juvenile idiopathic arthritis |
| Minimum duration | ≥6 wk | ≥6 wk |
| Age at onset | < 16 y | < 16 y |
| ≤ 4 joints in first 6 mo after presentation | Pauciarticular juvenile rheumatoid arthritis | Oligoarticular juvenile idiopathic arthritis: (A) Persistent < 4 joints for course of disease; (B) Extended >4 joints after 6 mo |
| >4 joints in first 6 mo after presentation | Polyarticular juvenile rheumatoid arthritis | Polyarticular juvenile idiopathic arthritis-rheumatoid factor negative Polyarticular juvenile arthritis-rheumatoid factor positive |
| Fever, rash, arthritis | Systemic juvenile rheumatoid arthritis | Systemic juvenile idiopathic arthritis |
| Other categories included | Exclusion of other forms | Psoriatic juvenile idiopathic arthritis Enthesitis-related arthritis Undifferentiated: (A) Fits no other category; (B) Fits more than 1 category |
| Inclusion of psoriatic arthritis, inflammatory bowel disease, juvenile ankylosing spondylitis | No | Yes |

